Photo courtesy NCI The US National Cancer Institute’s , ((NCI), development of a novel approach to immunotherapy, reported in the June issue of Nature Medicine, has been given wide coverage in the British press. It is an important step forward in our understanding of cancer mutation and treatment. The complex trial approach was in fact…Read more
About: Ian MacWatt
Recent Posts by Ian MacWatt
Studies of a blood test for 10 different types of cancers show promise as an early cancer screening process before patients show symptoms, Dr Eric Klein from the Taussig Cancer Institute of Cleveland, USA, told members at the annual conference of the American Society of Clinical Oncologists, (ASCO), in Chicago last week. The blood test,…Read more
Exercise is an essential component of successful Cancer treatment according to the Clinical Oncology Society of Australia, (COSA) latest . Position Statement, (18 May). It highlights the crucial exercise role in Cancer Care as adjunct therapy alongside surgery, chemotherapy or radiation. Rest and activity avoidance were historically an integral part of Cancer Care. But evidence…Read more
We tend to think of viruses as disease harbingers. Oncology researchers have found however that some viruses can be modified in the laboratory to infect and kill Cancer tumour cells while not harming healthy cells. A small but growing number of patients are benefiting from this new-targeted but presently exceedingly expensive viral treatment approach. After…Read more
Recent Comments by Ian MacWatt
No comments by Ian MacWatt yet.